Pittsburgh’s premier medical wellness center specializing in GLP-1 Medical Weight Loss (Semaglutide / Tirzepatide) and Testosterone Replacement Therapy (TRT), supported by targeted peptides and advanced T-Shape 2 body sculpting with Red Light Therapy.
Lose 15–20% of your body weight safely with prescription Semaglutide & Tirzepatide. Reset your hunger hormones without starvation or extreme workouts.
Restore youthful energy, lean muscle, focus, and drive with clinically supervised Testosterone Replacement Therapy tailored to your specific lab results.
Select what you want to achieve today, and we will match you with the exact physician-led protocol to get you there:
Designed to help you drop 15–20% of your body weight by quietly resetting gut satiety signals and removing food noise—allowing you to lose fat without starvation or intense hunger.
From prescription metabolic medications to advanced non-invasive body contouring equipment:
Prescription Semaglutide & Tirzepatide formulations to target hunger signals and burn stubborn fat.
Lab-guided testosterone therapy to restore muscle retention, energy, mental focus, and drive.
Targeted amino acid signaling compounds for advanced cellular healing, deep sleep, and muscular recovery.
Advanced T-Shape 2 contouring & Red/Infrared Light Therapy for skin tightening, collagen stimulation & cellulite reduction.
| Feature / Capability | Generic Diets / Med-Spas | Aeternus Medical Protocols |
|---|---|---|
| Physician Lab-Based Customization | Standardized one-size-fits-all | 100% Custom tailored to your blood labs |
| GLP-1 Prescription Access (Semaglutide / Tirzepatide) | Non-prescription supplements | FDA-compounded medical formulations |
| TRT & Hormone Balance | Not offered | Full endocrine monitoring & dose calibration |
| Ongoing Physician Progress Tracking | Self-guided | Regular doctor check-ins & Optimantra EMR Portal |
Existing patients can manage digital intake forms, message their care team, and access medical records via our secure Optimantra EMR Portal.
Access Patient Portal